MP07-66
CAY-42337-25 25 mg
Data Sheet: 
SDS:
SDS:
CAS
1938056-90-6
Formulation
A solution in ethanol
Purity
≥98%
MW
323,47026
Shipment
-20
Long Term Storage
-20
Shelf Life
730
Description
An inhibitor of the SET-PP2A protein-protein interaction; increases PP2A activity in isolated human B-CLL cells at 3 and 8 µM; does not decrease plasma membrane S1P1 levels in isolated human B-CLL cells at 8 µM; induces apoptosis in isolated human B-CLL cells when used alone or in combination with dasatinib
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
